Momentus Inc
For the period ended Sep 30, 2024. Filed Nov 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 14, 2024
MNTS$1.90-5.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(in thousands)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flows from operating activities: | ||
| Net loss | $(23,087) | $(54,819) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 657 | 667 |
| Amortization of debt discount and issuance costs | 88 | 1,182 |
| Amortization of right-of-use asset | 862 | 812 |
| Change in fair value of warrant liability | — | (559) |
| Loss on disposal of fixed and intangible assets | 188 | 17 |
| Stock-based compensation expense | 4,885 | 6,453 |
| Issuance of common stock for consulting services | — | 112 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | — | (44) |
| Prepaids and other current assets | 4,326 | (297) |
| Insurance receivable | (308) | — |
| Other non-current assets | (487) | 2,644 |
| Accounts payable | 2,872 | 278 |
| Accrued liabilities | (1,105) | (610) |
| Accrued interest | — | 118 |
| Other current liabilities | (6) | (2) |
| Contract liabilities | 640 | (1,098) |
| Operating lease liability | (944) | (859) |
| Litigation settlement contingency | 526 | — |
| Other non-current liabilities | 19 | 18 |
| Net cash used in operating activities | (10,874) | (45,987) |
| Cash flows from investing activities: | ||
| Purchases of property, machinery and equipment | — | (94) |
| Proceeds from sale of property, machinery and equipment | 135 | 113 |
| Purchases of intangible assets | (41) | (26) |
| Net cash provided by (used in) investing activities | 94 | (7) |
| Cash flows from financing activities: | ||
| Proceeds from issuance of convertible notes | 2,295 | — |
| Proceeds from exercise of stock options | — | 130 |
| Proceeds from employee stock purchase plan | — | 31 |
| Repurchase of Section 16 Officer shares for tax coverage exchange | (3) | (87) |
| Principal payments on loan payable | (2,319) | (9,592) |
| Payment of deferred offering costs | — | (252) |
| Payment for repurchase of common shares | — | (10,000) |
| Proceeds from issuance of common stock and related warrants | 10,750 | 15,000 |
| Payments for issuance costs related to common stock and related warrants | (1,137) | (1,135) |
| Net cash provided by (used in) financing activities | 9,586 | (5,905) |
| Decrease in cash, cash equivalents and restricted cash | (1,194) | (51,899) |
| Cash, cash equivalents and restricted cash, beginning of period | 2,492 | 62,413 |
| Cash, cash equivalents and restricted cash, end of period | $1,298 | $10,514 |
| Supplemental disclosure of non-cash investing and financing activities | ||
| Purchases of intangible assets in accounts payable and accrued expenses at period end | $20 | $5 |
| Issuance costs related to warrant modification | $1,272 | $648 |
| Issuance costs related to Placement Agent Warrants | $135 | $— |
| Supplemental disclosure of cash flow information | ||
| Cash paid for interest | $12 | $882 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.